Transthyretin V142I Genetic Variant and Cardiac Remodeling, Injury, and Heart Failure Risk in Black Adults

Authors:

Abstract
No abstract available
Funding Information
  • Amgen
  • National Institute on Minority Health and Health Disparities
  • Bristol-Myers Squibb
  • Jackson State University (HHSN268201800013I)
  • Pfizer
  • Mississippi State Department of Health (HHSN268201800015I)
  • Medtronic
  • Cooper Institute
  • Boehringer Ingelheim
  • Gilead Sciences
  • Novo Nordisk
  • Abbott Laboratories
  • Actelion Pharmaceuticals
  • National Heart, Lung, and Blood Institute
  • Roche
  • American Regent
  • National Institute of General Medical Sciences (5U54GM115428, P20GM104357)
  • Sanofi
  • National Institute of Diabetes and Digestive and Kidney Diseases (1K08DK099415- 01A1)
  • United Therapeutics Corporation
  • AstraZeneca
  • Boston Scientific Corporation
  • National Institutes of Health
  • Merck
  • Cytokinetics
  • National Institute on Aging (1R03AG067960-01)
  • Novartis
  • Bayer Fund

This publication has 16 references indexed in Scilit: